HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
Fang DD, Zhang B, Gu Q, Lira M, Xu Q, Sun H, Qian M, Sheng W, Ozeck M, Wang Z, Zhang C, Chen X, Chen KX, Li J, Chen SH, Christensen J, Mao M, Chan CC.
Fang DD, et al.
J Thorac Oncol. 2014 Mar;9(3):285-94. doi: 10.1097/JTO.0000000000000087.
J Thorac Oncol. 2014.
PMID: 24496003
Free article.